Inaugural Emerging Scholars Symposium scheduled for April 30
One of the most innovative of the “high-risk, high-reward” grant programs at the A. Alfred Taubman Medical Research Institute is the Emerging Scholars Program, which often is referred to as the “jewel in the crown” of the institute’s initiatives.
Not only do these grants support the current work of the best and brightest of the early-career clinician-scientists on the U-M Medical School faculty, they achieve the crucial goal of keeping our health science research pipeline full.
Talented, passionate physician-researchers with the vision and energy to solve complex medical puzzles should not be deterred for lack of funds. Thanks to the contributions of the generous donors who have pledged three years of funding for each scientist, the institute now is jump-starting the careers of 11 Emerging Scholars who combine their patient practice with cutting-edge research into cancer, neurological disorders and other complex diseases.
And now, the first-ever Emerging Scholars Symposium will present a morning of science featuring presentations by six of our remarkable Emerging Scholars, who are seeking new discoveries and treatments in fields ranging from ovarian cancer to major depression.
The Emerging Scholars Symposium will run from 10 a.m. to noon in the Kahn Auditorium of the A. Alfred Taubman Biomedical Science Research Building at U-M. For a map to the AAT-BSRB, click here.
The symposium is open to the entire University of Michigan community and to the general public. No registration is required.
To view a short video about the Emerging Scholars program, click here.
The presenting Emerging Scholars and their talks are:
Ron Buckanovich , M.D., Ph.D. “Developing Cancer Stem Cell Targeted Therapy to Prevent Disease Recurrence”
Sung Won Choi, M.D. “Histone deacetylase inhibition in graft-vs.-host disease”
Erika Newman , M.D. “Targeting Nonhomologous End-joining in Therapy-resistant Neuroblastoma”
Brian Mickey, M.D., Ph.D. “Biomarker Discovery for Refractory Mood Disorders”
Parag Patil, M.D., Ph.D. “Treating Movement Disorders and Depression with Deep-Brain Stimulation”
Srijan Sen, M.D., Ph.D. “Medical Internship as a Model to Identify Biological Predictors of Depression Under Stress”
Stem cell symposium set for Sept. 19 in Ann Arbor
Dr. Eva Feldman will be among the speakers at the one-day event, which focuses on cutting-edge developments in stem-cell biology, epigenetics and regneratrive medicine.
Click here for details and registration.
New Emerging Scholar named
Scott Tomlins, M.D., an assistant profesor of pathology at U-M, has been designated the A. Alfred Taubman Emerging Scholar. Dr. Tomlins is an expert in prostate cancer research.
People who care
Institute welcomes new gift officer
Maria Muller has been appointed to work with connect donors with funding opportunities at the Taubman Institute.
Click here to read more.
news & events
Institute symposium set for Oct. 10
The A. Alfred Taubman Medical Research Institute will award the 2014 $100,000 Taubman Prize for Excellence in Translational Medical Science at its 7th annual symposium at 10 a.m. on Oct. 10.
Dr. Carl June, a physician-scientist who developed a personalized immunotherapy for leukemia using patients’ own T cells, will receive the honor and deliver the symposium's keynote address.
Click here for symposium details.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Study: Two types of cancer stem cells lead to metastasis
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to a new study published by Taubman Senior Scholar Dr. Max Wicha.